Merck KGaA (MRK.DE) Financial Analysis & Valuation | Quarter Chart
Merck KGaA (MRK.DE)
MRK.DEPrice: $167.68
Fair Value: 🔒
🔒score
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industri... more
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science... more
Description
Shares
| Market Cap | $72.90B | Exchange | XETRA |
| Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
| Country | DE | CEO | Belen Garijo Lopez |
| IPO Date | 1998-06-26 | CAGR | 0.05% |
| Employees | 59,020 | Website | www.merckgroup.com |
| Div. Yield | 1.35% | Payout Ratio | 0.12% |
| Buy Back Yield | — | Total Yield | 1.35% |
MRK.DE chart loading...
Fundamentals
Technicals
| Enterprise Value | $64.01B | P/E Ratio | 17.46 |
| Forward P/E | 16.94 | PEG Ratio | -2.49 |
| P/S Ratio | 3.39 | P/B Ratio | 2.38 |
| P/CF Ratio | 16.87 | P/FCF Ratio | 29.29 |
| EPS | $9.6 | EPS Growth 1Y | -10.19% |
| EPS Growth 3Y | -21.88% | EPS Growth 5Y | 11.07% |
| Revenue Growth 1Y | -1.69% | Gross Margin | 0.59% |
| Operating Margin | 0.19% | Profit Margin | 0.12% |
| ROE | 0.09% | ROA | 0.05% |
| ROCE | 0.09% | Current Ratio | 1.51 |
| Quick Ratio | 1 | Cash Ratio | 0.29 |
| Debt/Equity | 0.4 | Interest Coverage | 9.46 |
| Altman Z Score | 3.05 | Piotroski Score | 7 |